Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds

Biomaterials

Volumn 34, Issue 2, 2013, Pages 452-459

  Lee, Sungsoo S ^a   Huang, Brian J ^a   Kaltz, Stuart R ^a   Sur, Shantanu ^b   Newcomb, Christina J ^a   Stock, Stuart R ^b   Shah, Ramille N ^a,b,c   Stupp, Samuel I ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

BMP 2 (bone morphogenetic protein 2); Bone regeneration; Heparan sulfate; Heparin; Peptide amphiphile; Regenerative medicine

Indexed keywords

BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; HEPARAN SULFATES; HEPARIN; PEPTIDE AMPHIPHILES; REGENERATIVE MEDICINE;

BIOACTIVITY; BIOMIMETICS; COLLAGEN; COMPUTERIZED TOMOGRAPHY; NANOFIBERS; POLYSACCHARIDES; SCAFFOLDS (BIOLOGY); SUPRAMOLECULAR CHEMISTRY; TISSUE;

BONE;

AMPHOPHILE; COLLAGEN; FIBRONECTIN; HEPARAN SULFATE; HEPARIN; NANOFIBER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SYNDECAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE REGENERATION; CONTROLLED STUDY; HISTOLOGY; LOW DRUG DOSE; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOMIMETIC MATERIALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; COLLAGEN; HEPARIN; HEPARITIN SULFATE; MALE; NANOFIBERS; PEPTIDES; RATS; RATS, INBRED LEW; TISSUE SCAFFOLDS;

ANIMALIA; RATTUS;

EID: 84868210528     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.005     Document Type: Article

References (63)

1. Taylor D., Hazenberg J.G., Lee T.C. Living with cracks: damage and repair in human bone. Nat Mater 2007, 6:263-268.
2. Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: an update. Injury 2005, 36:S20-S27.
3. De Long W.G., Einhorn T.A., Koval K., McKee M., Smith W., Sanders R., et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Jt Surg Am 2007, 89:649-658.
4. Banwart J.C., Asher M.A., Hassanein R.S. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995, 20:1055-1060.
5. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., Metters A.T., Weber F.E., Fields G.B., et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A 2003, 100:5413-5418.
6. Hollister S.J. Porous scaffold design for tissue engineering. Nat Mater 2005, 4:518-524.
7. Stupp S.I., Ciegler G.W. Organoapatites: materials for artificial bone. I. Synthesis and microstructure. J Biomed Mater Res A 1992, 26:169-183.
8. Muller-Mai C.M., Stupp S.I., Voigt C., Gross U. Nanoapatite and organoapatite implants in bone: histology and ultrastructure of the interface. J Biomed Mater Res A 1995, 29:9-18.
9. Stevens M.M. Biomaterials for bone tissue engineering. Mater Today 2008, 11:18-25.
10. Bueno E.M., Glowacki J. Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 2009, 5:685-697.
11. Palmer L.C., Newcomb C.J., Kaltz S.R., Spoerke E.D., Stupp S.I. Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel. Chem Rev 2008, 108:4754-4783.
12. Mouriño V., Boccaccini A.R. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J Roy Soc Interface 2010, 7:209-227.
13. Keating J.F., McQueen M.M. Substitutes for autologous bone graft in orthopaedic trauma. J Bone Joint Surg Br 2001, 83:3-8.
14. Haidar Z.S., Hamdy R.C., Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol Lett 2009, 31:1817-1824.
15. Haidar Z.S., Hamdy R.C., Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett 2009, 31:1825-1835.
16. Hsu W.K., Wang J.C. The use of bone morphogenetic protein in spine fusion. Spine J 2008, 8:419-425.
17. Jones A.L., Bucholz R.W., Bosse M.J., Mirza S.K., Lyon T.R., Webb L.X., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Jt Surg Am 2006, 88:1431-1441.
18. Gautschi O.P., Frey S.P., Zellweger R. Bone morphogenetic proteins in clinical applications. ANZ J Surg 2007, 77:626-631.
19. Julka A., Shah A.S., Miller B.S. Inflammatory response to recombinant human bone morphogenetic protein-2 use in the treatment of a proximal humeral fracture: a case report. J Shoulder Elbow Surg 2012, 21:e12-e16.
20. MacDonald K.M., Swanstrom M.M., McCarthy J.J., Nemeth B.A., Guliani T.A., Noonan K.J. Exaggerated inflammatory response after use of recombinant bone morphogenetic protein in recurrent unicameral bone cysts. J Pediatr Orthop 2010, 30:199-205.
21. Aro H.T., Govender S., Patel A.D., Hernigou P., Perera de Gregorio A., Popescu G.I., et al. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Jt Surg Am 2011, 93:801-808.
22. Lee K., Silva E.A., Mooney D.J. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 2011, 8:153-170.
23. Kolambkar Y., Boerckel J., Dupont K., Bajin M., Huebsch N., Mooney D.J., et al. Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. Bone 2011, 49:485-492.
24. Jongpoiboonkit L., Franklin-Ford T., Murphy W.L. Mineral-coated polymer microspheres for controlled protein binding and release. Adv Mater 2009, 21:1960-1963.
25. Benoit D.S., Collins S.D., Anseth K.S. Multifunctional hydrogels that promote osteogenic hMSC differentiation through stimulation and sequestering of BMP2. Adv Funct Mater 2007, 17:2085-2093.
26. Martino M.M., Tortelli F., Mochizuki M., Traub S., Ben-David D., Kuhn G.A., et al. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med 2011, 3:100ra89.
27. Capila I., Linhardt R.J. Heparin-protein interactions. Angew Chem Int Ed 2002, 41:391-412.
28. Takada T., Katagiri T., Ifuku M., Morimura N., Kobayashi M., Hasegawa K., et al. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 2003, 278:43229-43235.
29. Zhao B., Katagiri T., Toyoda H., Takada T., Yanai T., Fukuda T., et al. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem 2006, 281:23246-23253.
30. Kuo W.J., Digman M.A., Lander A.D. Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization. Mol Biol Cell 2010, 21:4028-4041.
31. Wierzbicka-Patynowski I., Schwarzbauer J.E. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003, 116:3269-3276.
32. Martino M.M., Hubbell J.A. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J 2010, 24:4711-4721.
33. Hartgerink J.D., Beniash E., Stupp S.I. Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials. Proc Natl Acad Sci U S A 2002, 99:5133-5138.
34. Hartgerink J.D., Beniash E., Stupp S.I. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001, 294:1684-1688.
35. Stendahl J., Rao M., Stupp S.I. Intermolecular Forces in the Self-Assembly of peptide amphiphile nanofibers. Adv Funct Mater 2006, 16:499-508.
36. Webber M.J., Tongers J., Newcomb C.J., Marquardt K.T., Bauersachs J., Losordo D.W., et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci U S A 2011, 108:13438-13443.
37. Huang Z., Newcomb C.J., Bringas P., Stupp S.I., Snead M.L. Biological synthesis of tooth enamel instructed by an artificial matrix. Biomaterials 2010, 31:9202-9211.
38. Webber M.J., Tongers J., Renault M.A., Roncalli J.G., Losordo D.W., Stupp S.I. Development of bioactive peptide amphiphiles for therapeutic cell delivery. Acta Biomater 2010, 6:3-11.
39. Silva G.A., Czeisler C., Niece K.L., Beniash E., Harrington D.A., Kessler J.A., et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004, 303:1352-1355.
40. Shah R.N., Shah N.A., Del Rosario Lim M.M., Hsieh C., Nuber G., Stupp S.I. Supramolecular design of self-assembling nanofibers for cartilage regeneration. Proc Natl Acad Sci U S A 2010, 107:3293-3298.
41. Matson J.B., Newcomb C.J., Bitton R., Stupp S.I. Nanostructure-templated control of drug release from peptide amphiphile nanofiber gels. Soft Matter 2012, 8:3586-3595.
42. Matson J.B., Stupp S.I. Drug release from hydrazone-containing peptide amphiphiles. Chem Commun 2011, 47:7962-7964.
43. Aida T., Meijer E.W., Stupp S.I. Functional supramolecular polymers. Science 2012, 335:813-817.
44. Matson J.B., Zha R.H., Stupp S.I. Peptide self-assembly for crafting functional biological materials. Curr Opin Solid State Mater Sci 2011, 15:225-235.
45. Mata A., Geng Y., Henrikson K.J., Aparicio C., Stock S.R., Satcher R.L., et al. Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix. Biomaterials 2010, 31:6004-6012.
46. Sargeant T.D., Guler M.O., Oppenheimer S.M., Mata A., Satcher R.L., Dunand D.C., et al. Hybrid bone implants: self-assembly of peptide amphiphile nanofibers within porous titanium. Biomaterials 2008, 29:161-171.
47. Rajangam K., Behanna H.A., Hui M.J., Han X., Hulvat J.F., Lomasney J.W., et al. Heparin binding nanostructures to promote growth of blood vessels. Nano Lett 2006, 6:2086-2090.
48. Rajangam K., Arnold M.S., Rocco M.A., Stupp S.I. Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity. Biomaterials 2008, 29:3298-3305.
49. Ghanaati S., Webber M.J., Unger R.E., Orth C., Hulvat J.F., Kiehna S.E., et al. Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers. Biomaterials 2009, 30:6202-6212.
50. Chow L.W., Bitton R., Webber M.J., Carvajal D., Shull K.R., Sharma A.K., et al. A bioactive self-assembled membrane to promote angiogenesis. Biomaterials 2011, 32:1574-1582.
51. Morgan M.R., Humphries M.J., Bass M.D. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 2007, 8:957-969.
52. O'Brien F.J., Harley B.A., Yannas I.V., Gibson L. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials 2004, 25:1077-1086.
53. de Belder A.N., Wik K.O. Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr Res 1975, 44:251-257.
54. Xu X., Jha A.K., Duncan R.L., Jia X. Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. Acta Biomater 2011, 7:3050-3059.
55. Crouzier T., Szarpak A., Boudou T., Auzely-Velty R., Picart C. Polysaccharide-blend multilayers containing hyaluronan and heparin as a delivery system for rhBMP-2. Small 2010, 6:651-662.
56. Geiger M., Li R.H., Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003, 55:1613-1629.
57. Murphy C.M., Haugh M.G., O'Brien F.J. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010, 31:461-466.
58. Yasko A.W., Lane J.M., Fellinger E.J., Rosen V., Wozney J.M., Wang E.A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 1992, 74:659-670.
59. McCarthy I. The physiology of bone blood flow: a review. J Bone Joint Surg Am 2006, 88(Suppl. 3):4-9.
60. Barnes G.L., Kostenuik P.J., Gerstenfeld L.C., Einhorn T.A. Growth factor regulation of fracture repair. J Bone Miner Res 1999, 14:1805-1815.
61. Patel Z.S., Young S., Tabata Y., Jansen J.A., Wong M.E., Mikos A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43:931-940.
62. Minear S., Leucht P., Jiang J., Liu B., Zeng A., Fuerer C., et al. Wnt proteins promote bone regeneration. Sci Transl Med 2010, 2:29ra30.
63. Oest M.E., Dupont K.M., Kong H.-J., Mooney D.J., Guldberg R.E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 2007, 25:941-950.